There’s a lot converging on investors today. Let’s sort it out. All signs were there for the coronavirus to move from a phase of containment to mitigation. Still, people have been surprised. There was a genuine surprise that Russia would declare war on American shale producers by failing to go
As the coronavirus spreads across the U.S., the question I am being most often asked is how low can the stock market go. Let’s examine this question with the help of two charts. Charts Please click here for a long-term monthly chart of the Dow Jones Industrial Average ETF DIA which tracks the
The Federal Reserve on Tuesday announced an emergency interest-rate cut to counter the effects of the coronavirus on the economy. Expect calls for more spending on the fiscal side to increase the deficit from a trillion-plus dollars. Where is the money going to come from? The answer is easy: Just
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
The coronavirus is spreading. The stock market is under pressure. Investors are reacting — badly. The No. 1 mistake investors are making now in the wake of coronavirus has to do with their artificial construct of the true nature of the stock market. Reality and this construct simply do not
Earlier this morning, we gave a signal to take profit on MRNA around $2.70. However MRNA is opening up around $2.25. We recommend exiting at $2.25 for over 35% profit in one day www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
We are short from $3.51 in pre market as our analysis does not justify the share price appreciation from the approval of generic calcitonin-salmon nasal spray for the treatment of osteoporosis www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY